PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Camphor→

Camphor PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
76-22-2
Molecular formula
C10H16O
Molecular weight
152.23 g/mol
Drug class
Topical counterirritantterpene ketone used in external analgesic preparations
Mechanism of action
Produces a local cooling and counterirritant sensation through effects on transient receptor potential (TRP) channels in cutaneous sensory neurons. The perceived cooling and counterirritant response can transiently reduce awareness of superficial pain or itching.
Indications / reported uses
  • Temporary relief of minor muscle and joint aches when used in topical external analgesic products
  • Symptomatic relief of minor itching or irritation in selected topical formulations; do not apply to broken skin or use by ingestion

Sources: US eCFR — External analgesic drug products, 21 CFR Part 348 · PubChem — Camphor · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Camphor PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Camphor Permitted Daily Exposure (PDE) report (the Camphor PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Camphor Occupational Exposure Limit (OEL) report (the Camphor OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.